CALCIMEDICA(CALC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CALC CALCIMEDICA

休市中 02-06 16:00:00 EST

0.6001

-0.0108

-1.77%

盘后0.6282

+0.0281+4.68%

19:44 EST

最高0.6597	最低0.5797	成交量56.94万
今开0.5894	昨收0.6109	日振幅13.10%
总市值864.71万	流通市值401.84万	总股本1,441万
成交额35.06万	换手率8.50%	流通股本669.63万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CALC","market":"US","secType":"STK","nameCN":"CALCIMEDICA","latestPrice":0.6001,"timestamp":1770411600000,"preClose":0.6109,"halted":0,"volume":569426,"hourTrading":{"tag":"盘后","latestPrice":0.6282,"preClose":0.6001,"latestTime":"19:44 EST","volume":8208,"amount":4994.8997,"timestamp":1770425048290,"change":0.0281,"changeRate":0.046826,"amplitude":0.083486},"delay":0,"changeRate":-0.017678834506465922,"floatShares":6696300,"shares":14409400,"eps":-1.613603,"marketStatus":"休市中","change":-0.0108,"latestTime":"02-06 16:00:00 EST","open":0.5894,"high":0.6597,"low":0.5797,"amount":350596.9548224,"amplitude":0.130954,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.613603,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":0.6109,"preHourTrading":{"tag":"盘前","latestPrice":0.597,"preClose":0.6109,"latestTime":"09:28 EST","volume":16109,"amount":9510.68513675,"timestamp":1770388102122,"change":-0.0139,"changeRate":-0.022753,"amplitude":0.035521},"postHourTrading":{"tag":"盘后","latestPrice":0.6282,"preClose":0.6001,"latestTime":"19:44 EST","volume":8208,"amount":4994.8997,"timestamp":1770425048290,"change":0.0281,"changeRate":0.046826,"amplitude":0.083486},"volumeRatio":0.37807247873522964,"impliedVol":1.8027,"impliedVolPercentile":0.2778},"requestUrl":"/m/hq/s/CALC/wiki","defaultTab":"wiki","newsList":[{"id":"1145838806","title":"CalciMedica调整财务指引：终止临床试验后，现预期资金可支撑至2026年第四季度——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1145838806","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145838806?lang=zh_cn&edition=full","pubTime":"2026-01-29 06:32","pubTimestamp":1769639544,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件显示，生物制药公司CalciMedica在终止某项临床试验后，已更新其财务运营规划。该公司目前预计，现有资金储备可维持公司运营至2026年第四季度，较先前预期有所延长。\n这一调整反映出CalciMedica在优化研发支出与现金流管理方面取得的进展。临床试验的终止虽可能影响研发进程，但通过重新分配资源，公司成功延长了资金续航能力。此番财务指引的更新，为市场提供了评估其长期财务健康度的新基准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"1111803537","title":"CalciMedica试验中无死亡病例被认定与研究药物相关","url":"https://stock-news.laohu8.com/highlight/detail?id=1111803537","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111803537?lang=zh_cn&edition=full","pubTime":"2026-01-28 20:09","pubTimestamp":1769602170,"startTime":"0","endTime":"0","summary":"在CalciMedica Inc开展的临床试验中，经研究人员及公司方面评估，未出现任何与研究药物存在关联性的死亡病例。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"1134177096","title":"CalciMedica宣布根据独立数据监察委员会建议中止急性肾损伤二期Kourage试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1134177096","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134177096?lang=zh_cn&edition=full","pubTime":"2026-01-28 20:02","pubTimestamp":1769601756,"startTime":"0","endTime":"0","summary":"生物制药公司CalciMedica依据独立数据监察委员会的评估建议，决定终止其针对急性肾损伤患者的二期临床试验Kourage研究项目。该决定基于对试验中期数据的全面审查，表明继续研究不符合患者权益最大化原则。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2605482965","title":"Calcimedica, Inc.盘中异动 早盘急速拉升6.25%报5.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605482965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605482965?lang=zh_cn&edition=full","pubTime":"2026-01-21 22:58","pubTimestamp":1769007522,"startTime":"0","endTime":"0","summary":"北京时间2026年01月21日22时58分，Calcimedica, Inc.股票出现波动，股价大幅上涨6.25%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Lisata Therapeutics, Inc.、Moolec Science Sa、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Revelation Biosciences, Inc.、Lisata Therapeutics, Inc.较为活跃，换手率分别为878.31%、74.66%、40.02%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Jasper Therapeutics Inc C/Wts 24/09/2026 、Aditxt, Inc.，振幅分别为49.38%、47.55%、35.58%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121225843a44623ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121225843a44623ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC","CRAC","BK4007"],"gpt_icon":0},{"id":"2602300909","title":"Calcimedica, Inc.盘中异动 早盘股价大涨6.00%报5.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602300909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602300909?lang=zh_cn&edition=full","pubTime":"2026-01-10 00:16","pubTimestamp":1767975414,"startTime":"0","endTime":"0","summary":"北京时间2026年01月10日00时16分，Calcimedica, Inc.股票出现波动，股价快速拉升6.00%。截至发稿，该股报5.65美元/股，成交量4.1624万股，换手率0.29%，振幅6.57%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110001655a7081243&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110001655a7081243&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC","CRAC","BK4007"],"gpt_icon":0},{"id":"2595975866","title":"Calcimedica, Inc.盘中异动 临近午盘股价大跌5.02%报5.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595975866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595975866?lang=zh_cn&edition=full","pubTime":"2025-12-30 00:40","pubTimestamp":1767026423,"startTime":"0","endTime":"0","summary":"北京时间2025年12月30日00时40分，Calcimedica, Inc.股票出现波动，股价大幅跳水5.02%。截至发稿，该股报5.92美元/股，成交量1.499万股，换手率0.10%，振幅5.29%。Calcimedica, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230004024a486cd5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230004024a486cd5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRAC","CALC","BK4007"],"gpt_icon":0},{"id":"2592168081","title":"【对标分析】CALB 324Ah重卡电池模组相关信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2592168081","media":"Ofweek光电信息网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592168081?lang=zh_cn&edition=full","pubTime":"2025-12-19 18:06","pubTimestamp":1766138760,"startTime":"0","endTime":"0","summary":"#CALB#中航#重卡#324Ah早些时候，我们拆解了CATL 324Ah重卡模组。相关信息，见文章：CATL 324Ah重卡模组相关信息近期，我们拆解了CALB 324Ah重卡模组，相关图片和简要信息如下图所示：同样是应用在重卡领域的电池组，CALB和CATL的一些设计点各有千秋。但是一些差异点如下：1）CALB模组的整体结构强度设计，没有像CATL设计的那么Robust。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219181553a6b6b39d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219181553a6b6b39d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1993786604.SGD","LU0880133367.SGD","300750","03750","LU0067412154.USD","LU1807302812.USD","LU1008478684.HKD","LU1152091754.HKD","LU1960683339.HKD","BK1610","BK1116","CALC","LU1152091168.USD"],"gpt_icon":0},{"id":"2592459699","title":"Calcimedica, Inc.盘中异动 急速下跌5.27%报4.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592459699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592459699?lang=zh_cn&edition=full","pubTime":"2025-12-18 00:54","pubTimestamp":1765990472,"startTime":"0","endTime":"0","summary":"北京时间2025年12月18日00时54分，Calcimedica, Inc.股票出现异动，股价急速下挫5.27%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Processa Pharmaceuticals, Inc.、Vyne Therapeutics Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Aditxt, Inc.、Pmgc Holdings Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为1960.90%、1131.24%、810.47%，振幅较大的相关个股有Processa Pharmaceuticals, Inc.、Vyne Therapeutics Inc.、Aditxt, Inc.，振幅分别为186.35%、46.91%、46.48%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218005433953b658e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218005433953b658e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRAC","CALC","BK4007"],"gpt_icon":0},{"id":"2586298729","title":"Calcimedica, Inc.盘中异动 股价大跌7.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586298729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586298729?lang=zh_cn&edition=full","pubTime":"2025-11-26 22:37","pubTimestamp":1764167821,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日22时37分，Calcimedica, Inc.股票出现波动，股价急速下跌7.67%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Liminatus Pharma Inc C/Wts 30/04/2030 、Scisparc Ltd.涨幅较大，Scisparc Ltd.、Kala Bio, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为1918.64%、157.68%、41.85%，振幅较大的相关个股有Quantum Biopharma Ltd.、Revolution Medicines Inc C/Wts 17/12/2026 、Scisparc Ltd.，振幅分别为28.61%、25.50%、14.75%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126223701a713344e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126223701a713344e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2584260248","title":"Calcimedica, Inc.盘中异动 下午盘大幅拉升5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584260248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584260248?lang=zh_cn&edition=full","pubTime":"2025-11-18 02:25","pubTimestamp":1763403954,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日02时25分，Calcimedica, Inc.股票出现异动，股价急速上涨5.67%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为1.63%。其相关个股中，Applied Therapeutics, Inc.、Annovis Bio, Inc.、Zymeworks Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Clearmind Medicine Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为1700.20%、184.22%、137.37%，振幅较大的相关个股有Applied Therapeutics, Inc.、Annovis Bio, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为79.34%、70.26%、58.62%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118022554a4a83f4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118022554a4a83f4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2584469646","title":"Calcimedica, Inc.2025财年第三财季实现净利润-7.80百万美元，同比减少38.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584469646","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584469646?lang=zh_cn&edition=full","pubTime":"2025-11-17 00:03","pubTimestamp":1763308982,"startTime":"0","endTime":"0","summary":"11月17日，Calcimedica, Inc.公布财报，公告显示公司2025财年第三财季净利润为-7.80百万美元，同比减少38.79%；其中营业收入为0.00美元，每股基本收益为-0.52美元。从资产负债表来看，Calcimedica, Inc.总负债15.18百万美元，其中短期债务0.00美元，资产负债比为0.99，流动比率为4.04。机构评级：截至2025年11月17日，当前有4家机构对Calcimedica, Inc.目标价做出预测，其中目标均价为16.25美元，其中最低目标价为14.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111700034295081820&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111700034295081820&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC"],"gpt_icon":0},{"id":"2583133475","title":"Calcimedica, Inc.盘中异动 早盘股价大跌5.39%报3.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583133475","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583133475?lang=zh_cn&edition=full","pubTime":"2025-11-13 22:34","pubTimestamp":1763044451,"startTime":"0","endTime":"0","summary":"北京时间2025年11月13日22时34分，Calcimedica, Inc.股票出现波动，股价快速下挫5.39%。Calcimedica, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Mersana Therapeutics, Inc.、Clearmind Medicine Inc.、Cdt Equity Inc C/Wts 22/09/2028涨幅较大，Clearmind Medicine Inc.、Salarius Pharmaceuticals, Inc.、Mersana Therapeutics, Inc.较为活跃，换手率分别为1696.16%、288.71%、29.99%，振幅较大的相关个股有Clearmind Medicine Inc.、Nextcure, Inc.、Mersana Therapeutics, Inc.，振幅分别为45.12%、12.06%、11.16%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113223411a49f47cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113223411a49f47cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2582349467","title":"Calcimedica, Inc.盘中异动 股价大涨7.19%报3.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582349467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582349467?lang=zh_cn&edition=full","pubTime":"2025-11-12 02:05","pubTimestamp":1762884300,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日02时05分，Calcimedica, Inc.股票出现波动，股价快速上涨7.19%。截至发稿，该股报3.28美元/股，成交量2633股，换手率0.02%，振幅7.19%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为1.57%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112020501a6f284a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112020501a6f284a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2582994870","title":"Calcimedica, Inc.盘中异动 股价大涨5.10%报3.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582994870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582994870?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:42","pubTimestamp":1762785762,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时42分，Calcimedica, Inc.股票出现波动，股价大幅拉升5.10%。截至发稿，该股报3.20美元/股，成交量2527股，换手率0.02%，振幅0.00%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110224243a4978ae8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110224243a4978ae8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2577120304","title":"Calcimedica, Inc.盘中异动 股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577120304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577120304?lang=zh_cn&edition=full","pubTime":"2025-10-22 23:35","pubTimestamp":1761147357,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日23时35分，Calcimedica, Inc.股票出现异动，股价快速下挫5.37%。Calcimedica, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022233557a6c84c47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022233557a6c84c47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2569273690","title":"Calcimedica, Inc.盘中异动 早盘大幅拉升5.96%报3.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569273690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569273690?lang=zh_cn&edition=full","pubTime":"2025-09-22 21:48","pubTimestamp":1758548889,"startTime":"0","endTime":"0","summary":"北京时间2025年09月22日21时48分，Calcimedica, Inc.股票出现波动，股价快速拉升5.96%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Metsera, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Onconetix, Inc.、Gri Bio, Inc.较为活跃，换手率分别为2360.74%、137.84%、40.51%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Onconetix, Inc.、Mbx Biosciences, Inc.，振幅分别为68.66%、42.05%、33.50%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922214809a72f8d03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922214809a72f8d03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2568371211","title":"Calcimedica, Inc.盘中异动 下午盘股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568371211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568371211?lang=zh_cn&edition=full","pubTime":"2025-09-20 02:30","pubTimestamp":1758306652,"startTime":"0","endTime":"0","summary":"北京时间2025年09月20日02时30分，Calcimedica, Inc.股票出现波动，股价快速跳水5.29%。Calcimedica, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920023052a4378a85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920023052a4378a85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2567176805","title":"Calcimedica, Inc.盘中异动 股价大跌10.09%报2.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567176805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567176805?lang=zh_cn&edition=full","pubTime":"2025-09-15 22:02","pubTimestamp":1757944968,"startTime":"0","endTime":"0","summary":"北京时间2025年09月15日22时02分，Calcimedica, Inc.股票出现异动，股价急速跳水10.09%。截至发稿，该股报2.85美元/股，成交量8977股，换手率0.06%，振幅7.89%。Calcimedica, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915220248a4c79ab4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915220248a4c79ab4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2562770244","title":"Calcimedica, Inc.盘中异动 快速拉升6.33%报3.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562770244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562770244?lang=zh_cn&edition=full","pubTime":"2025-08-28 03:47","pubTimestamp":1756324051,"startTime":"0","endTime":"0","summary":"北京时间2025年08月28日03时47分，Calcimedica, Inc.股票出现波动，股价急速拉升6.33%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Novabay Pharmaceuticals, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Azitra Inc涨幅较大，Azitra Inc、Novabay Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为3071.38%、2371.39%、2096.98%，振幅较大的相关个股有Azitra Inc、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为56.73%、50.65%、50.00%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828034731a4a335cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828034731a4a335cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4007","BK4588","LC","CALC","BK4166"],"gpt_icon":0},{"id":"2560927209","title":"Calcimedica, Inc.2025财年第二财季实现净利润-5.96百万美元，同比减少50.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560927209","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560927209?lang=zh_cn&edition=full","pubTime":"2025-08-18 00:02","pubTimestamp":1755446527,"startTime":"0","endTime":"0","summary":"8月18日，Calcimedica, Inc.公布财报，公告显示公司2025财年第二财季净利润为-5.96百万美元，同比减少50.89%；其中营业收入为0.00美元，每股基本收益为-0.40美元。从资产负债表来看，Calcimedica, Inc.总负债12.98百万美元，其中短期债务0.00美元，资产负债比为1.47，流动比率为5.45。机构评级：截至2025年8月18日，当前有4家机构对Calcimedica, Inc.目标价做出预测，其中目标均价为16.25美元，其中最低目标价为14.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818000445a6eb4ee0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818000445a6eb4ee0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.calcimedica.com","stockEarnings":[{"period":"1week","weight":-0.3332},{"period":"1month","weight":-0.8962},{"period":"3month","weight":-0.8026},{"period":"6month","weight":-0.781},{"period":"1year","weight":-0.7786},{"period":"ytd","weight":-0.9089}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CalciMedica, Inc.于2015年2月根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。公司候选产品作用于钙释放活化钙（“CRAC”）通道，将构成一类新药。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.093409},{"month":2,"riseRate":0,"avgChangeRate":-0.238779},{"month":3,"riseRate":0,"avgChangeRate":-0.267862},{"month":4,"riseRate":0.2,"avgChangeRate":-0.060527},{"month":5,"riseRate":0.4,"avgChangeRate":-0.021756},{"month":6,"riseRate":0.6,"avgChangeRate":0.059496},{"month":7,"riseRate":0.4,"avgChangeRate":0.139558},{"month":8,"riseRate":0.4,"avgChangeRate":-0.05924},{"month":9,"riseRate":0.4,"avgChangeRate":-0.051303},{"month":10,"riseRate":0.4,"avgChangeRate":-0.031218},{"month":11,"riseRate":0.5,"avgChangeRate":0.215716},{"month":12,"riseRate":0.5,"avgChangeRate":-0.013468}],"exchange":"NASDAQ","name":"CALCIMEDICA","nameEN":"CALCIMEDICA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CALCIMEDICA(CALC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CALCIMEDICA(CALC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CALCIMEDICA,CALC,CALCIMEDICA股票,CALCIMEDICA股票老虎,CALCIMEDICA股票老虎国际,CALCIMEDICA行情,CALCIMEDICA股票行情,CALCIMEDICA股价,CALCIMEDICA股市,CALCIMEDICA股票价格,CALCIMEDICA股票交易,CALCIMEDICA股票购买,CALCIMEDICA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CALCIMEDICA(CALC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CALCIMEDICA(CALC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}